Subsection 2: Cross-disciplinary provisions on quality in cancer research

I.-The authorisation may only be granted if the applicant has an organisation, set up where appropriate jointly with other cancer treatment authorisation holders, which ensures that each patient is treated throughout the course of the disease and in accordance with the best practice guidelines defined by the Institut national du cancer in application of 2° of article L. 1415-2 : 1° Assessment of patients’ needs and access to the necessary…

I.-The holder of the authorisation organises the continuity of care and, where appropriate, the coordination of care for the patients it treats, within the establishment and by means of agreements with other establishments or persons holding the authorisation referred to in article R. 6123-86-1. II.-It has an organisation for the treatment of complications and emergency situations, under the same conditions as those mentioned in I. This organisation is set up,…

I.-The holder of the authorisation collects and sends to the Regional Health Agency and the National Cancer Institute, on an annual basis, anonymised indicators for monitoring the quality of its healthcare activity, set by order of the Minister for Health on a proposal from the National Cancer Institute. II – For each authorised cancer treatment modality, a self-assessment of care activity practices is carried out annually in the establishment as…

I.-The provisions of the present sub-section also apply to holders of neurosurgery authorisations, when they perform therapeutic procedures aimed at curing cancerous tumours and associated with this authorisation, with the exception of the provisions of 2° of article R. 6123-91-1 and articles R. 6123-91-4 and R. 6123-91-12.